Perfromance Wealth Partners, LLC Johnson & Johnson Transaction History

Perfromance Wealth Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$155.75 - $174.48 $102,795 - $115,156	660 Added 1.26%	53,086 $8.27 Million
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $303,297 - $326,406	-1,965 Reduced 3.61%	52,426 $8.68 Million
Q1 2023 Apr 20, 2023	BUY	$151.05 - $180.26 $17,672 - $21,090	117 Added 0.22%	54,391 $8.43 Million
Q4 2022 Jan 19, 2023	SELL	$160.2 - $179.79 $188,074 - $211,073	-1,174 Reduced 2.12%	54,274 $0
Q3 2022 Oct 17, 2022	BUY	$161.33 - $179.52 $440,592 - $490,269	2,731 Added 5.18%	55,448 $9.06 Million
Q2 2022 Jul 15, 2022	BUY	$168.19 - $186.01 $3.11 Million - $3.44 Million	18,512 Added 54.12%	52,717 $9.36 Million
Q1 2022 Apr 21, 2022	BUY	$158.14 - $179.59 $3.46 Million - $3.93 Million	21,869 Added 177.28%	34,205 $6.06 Million
Q4 2021 Feb 03, 2022	BUY	$155.93 - $173.01 $1.92 Million - $2.13 Million	12,336 New	12,336 $2.11 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.